CMS released its Calendar Year 2027 Medicare Physician Fee Schedule proposed rule on July 14, and the headline number is a cut. Both Medicare conversion factors, the dollar multiplier that converts a service’s relative value into an actual payment, are set to fall, because the one-time 2.5 percent payment increase Congress provided for 2026 does not carry forward into 2027. That is a real, system-wide reimbursement headwind affecting every Medicare-billing physician, psychiatrists included. It is also not the whole story in this rule for behavioral health specifically, and the parts that are not the headline number are worth reading closely.
The cut, precisely
The statute requires two separate conversion factors: one for clinicians who qualify as participants in an Advanced Alternative Payment Model, one for those who do not. For 2027, CMS proposes a positive statutory update of 0.75 percent for the qualifying rate and 0.25 percent for the non-qualifying rate, partly offset by a 0.53 percent increase tied to proposed changes in work relative value units. Against that, the one-year 2.5 percent bump that applied only to 2026 disappears entirely. Net effect: the qualifying conversion factor falls roughly 1.19 percent, the non-qualifying rate roughly 1.68 percent, year over year. This is not a policy choice specific to psychiatry or behavioral health; it is a structural, statutory reset that touches the entire Medicare physician payment system.
The part specific to behavioral health, and it runs the other direction
Inside the same proposed rule, CMS is proposing conforming regulatory changes to implement a provision of the Consolidated Appropriations Act, 2026, that would waive the in-person visit requirement for Medicare mental health telehealth visits entirely through December 31, 2027. Under the standing rule this replaces, a Medicare beneficiary receiving mental health treatment via telehealth has needed an in-person visit within six months before starting virtual care, and at least one in-person visit every twelve months to continue it, a real friction point for fully remote psychiatric and therapy practices. The proposed extension removes that friction for another full year. This sits alongside, and is a distinct mechanism from, the DEA’s separate, already-extended waiver of in-person requirements for telehealth prescribing of controlled substances, which this desk has covered directly. Between the two, the regulatory environment for fully virtual psychiatric care, both the prescribing side and the general mental health visit side, remains extended rather than tightening, at least through the end of next year.
A second favorable detail, buried in last year’s rule but still relevant
The most contested provision in the CY 2026 rule was a 2.5 percent “efficiency adjustment,” a downward reduction to the work relative value units and intraservice time of non-time-based services, procedures, radiology, diagnostic tests, on the theory that procedural medicine gets more efficient over time in a way time-based medicine does not. Time-based codes were explicitly exempted from that reduction, and psychiatric evaluation and management, psychotherapy, and most behavioral health integration billing run on time-based codes. That exemption is not new to the 2027 rule, but it means behavioral health specialties enter this reimbursement cycle already structurally shielded from at least one specific cut mechanism that procedural specialties are not, a real, if narrow, advantage worth knowing sits in the background of any broader conversation about Medicare psychiatric reimbursement.
Why this matters beyond the percentage points
This rule is genuinely consequential for reimbursement pathways tied to ketamine, esketamine, digital therapeutics, and any near-term psychedelic approval, but the mechanism is more specific than a blanket cut. Every one of those categories bills partly or entirely through time-based behavioral health codes, meaning the conversion-factor cut applies to their base rate, but the specific cut mechanism that hit procedural specialties hardest largely does not. And for the digital and telehealth-delivered side of that list specifically, the proposed in-person-visit waiver extension is a direct, favorable input into exactly the reimbursement-versus-access calculus this desk tracked in its coverage of the cash-pay telehealth psychiatry model, more evidence that the insurance-reimbursement side of that market continues to get easier to access via telehealth, not harder, even as the underlying base payment rate falls.
The caveats
This is a proposed rule, not a final one. The 60-day public comment period runs through September 14, 2026, the same date, coincidentally, as the FDA’s separate public hearing on the future of psychedelic therapies, and CMS can and does revise proposals in response to comments before finalizing later in the year. The specific dollar conversion-factor figures reported across early coverage of the rule vary slightly depending on rounding and which baseline is used; the direction and rough magnitude of the cut are consistent across sources, the exact cents are not yet settled. And none of the favorable behavioral-health-specific provisions offset the base-rate cut; they narrow its relative impact on this specialty compared to others, they do not reverse it.
The frame
A Medicare physician fee schedule is exactly the kind of unglamorous document this desk exists to read closely rather than skim for a headline. The top-line story, Medicare is cutting physician pay for 2027, is accurate and real. The fuller story is that behavioral health enters this cycle with two structural protections procedural medicine does not have, a telehealth mental health flexibility being extended rather than curtailed, and an exemption from last year’s most contested efficiency cut, sitting inside the same rule that cuts everyone’s base rate. Neither detail was the headline anywhere this rule got covered generally. Both are exactly the kind of provision that determines what psychiatric evaluation, psychotherapy, ketamine and esketamine treatment, and eventually psychedelic-assisted therapy actually get paid, and by whom, over the next several years. The comment period is open. The specifics are where this one actually lives.